{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:52:23Z","timestamp":1775811143197,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/coc.0b013e31827e52a3","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T14:10:21Z","timestamp":1362492621000},"page":"461-466","source":"Crossref","is-referenced-by-count":57,"title":["Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer"],"prefix":"10.1097","volume":"37","author":[{"given":"Melissa P.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Sam","family":"Beddar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc E.","family":"Delclos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1001\/jama.299.16.1914","article-title":". Fluorouracil, mitomycin, and radiotherapy versus fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.","volume":"299","author":"Ajani","year":"2008","journal-title":"J Am Med Assoc"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijrobp.2005.05.052","article-title":". Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinalfemoral nodes.","volume":"63","author":"Chen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-2-41","article-title":". Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans.","volume":"2","author":"Menkarios","year":"2007","journal-title":"Radiat Oncol"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":". Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.","volume":"63","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ijrobp.2009.09.046","article-title":". Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.","volume":"78","author":"Pepek","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":". Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":". Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":". Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.","volume":"25","author":"Salama","year":"2007","journal-title":"J Clin Oncol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clon.2011.09.014","article-title":". Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinomaclinical outcomes in a large National Cancer Institute-designated integrated cancer centre network.","volume":"24","author":"Defoe","year":"2012","journal-title":"Clin Oncol"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2012.05.011","article-title":". Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients.","volume":"104","author":"Briere","year":"2012","journal-title":"Radiother Oncol"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","article-title":". Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.","volume":"68","author":"Das","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1002\/cncr.25188","article-title":". Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11).","volume":"116","author":"Ajani","year":"2010","journal-title":"Cancer"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":". Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1200\/JCO.2008.19.6857","article-title":". US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.","volume":"27","author":"Ajani","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e31827e52a3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:09:28Z","timestamp":1620950968000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201410000-00008"}},"subtitle":["Outcomes and Toxicity"],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31827e52a3","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}